Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
CNCR Stock Price Chart Interactive Chart >
CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $14.06 | 52-week high | $31.41 |
| Prev. close | $14.16 | 52-week low | $12.76 |
| Day low | $14.06 | Volume | 1,035 |
| Day high | $14.35 | Avg. volume | 6,924 |
| 50-day MA | $16.19 | Dividend yield | 13.18% |
| 200-day MA | $17.59 |
Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio
The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.
CNCR ETF Info
| Issuer | Exchange Traded Concepts |
| Expense Ratio | 0.79% |
| Underlying Index | Loncar Cancer Immunotherapy Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 21.79M |
| Net Asset Value (NAV) | $14.06 |
| Options? | Yes |
| Total Holdings | 32 |
CNCR Top Holdings
| Symbol | Company | % of Total |
| IMCR | IMMUNOCORE HOLDINGS PLC-ADR | 0.04% |
| LYEL | Lyell Immunopharma Inc | 0.04% |
| IGMS | IGM Biosciences Inc | 0.04% |
| IOVA | Iovance Biotherapeutics Inc | 0.04% |
| REGN | Regeneron Pharmaceuticals Inc | 0.04% |
| XNCR | Xencor Inc | 0.04% |
| GMAB | Genmab A/S | 0.04% |
| RCUS | ARCUS BIOSCIEN | 0.04% |
| FATE | FATE THERAPEUTIC | 0.04% |
CNCR Price Returns
| 1-mo | -10.79% |
| 3-mo | -7.03% |
| 6-mo | -22.45% |
| 1-year | -51.18% |
| 3-year | -17.69% |
| 5-year | -42.04% |
| YTD | -40.92% |
| 2021 | -19.24% |
| 2020 | 36.53% |
| 2019 | 24.22% |
| 2018 | -20.65% |
| 2017 | 13.61% |
CNCR Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||